ARCA biopharma, Inc. (ABIO) SEC filings
ABIO SEC filings moved a median of -0.61% by the close. ABIO SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the ABIO overview →
31 measured ABIO SEC filing events.
Where these ABIO SEC filings landedvs 29 measured ABIO SEC filing reactions
| Middle 50% of ABIO SEC filing reactions | -2.72% to +3.19% |
|---|---|
| Median reaction (to close) | -0.61% |
| Measured reactions | 29 |
Point-in-time · zero look-ahead
Half of the 29 ABIO SEC filing events with a measured close landed between -2.72% and +3.19%; 45% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 8-K Oruka Therapeutics, Inc. For: Sep 11 | SEC filing · Form 8-K | — | — | |
| Form 8-K Oruka Therapeutics, Inc. For: Aug 29 | SEC filing · Form 8-K | — | — | |
| Form 8-K ARCA biopharma, Inc. For: Aug 26 | SEC filing · Form 8-K | +0.14% | +2.38% | |
| Form SEC STAFF LETTER ARCA biopharma, Inc. | SEC filing · Form SEC | — | +3.12% | |
| Form 8-K ARCA biopharma, Inc. For: Aug 22 | SEC filing · Form 8-K | -4.56% | -3.54% | |
| Form 8-K ARCA biopharma, Inc. For: Aug 16 | SEC filing · Form 8-K | +5.84% | +16.23% | |
| Form 8-K ARCA biopharma, Inc. For: Aug 14 | SEC filing · Form 8-K | +0.00% | +3.87% | |
| Form 10-Q ARCA biopharma, Inc. For: Jun 30 | SEC filing · Form 10-Q | -1.16% | +3.32% | |
| Form 8-K ARCA biopharma, Inc. For: Aug 01 | SEC filing · Form 8-K | -1.16% | +3.32% | |
| Form EFFECT ARCA biopharma, Inc. | SEC filing · Form EFFECT | +1.45% | -0.97% | |
| Form ARS ARCA biopharma, Inc. For: Dec 31 | SEC filing · Form ARS | +1.45% | -0.97% | |
| Form S-4/A ARCA biopharma, Inc. | SEC filing · Form S-4 | +0.00% | -4.29% | |
| Form 8-K ARCA biopharma, Inc. For: Jul 03 | SEC filing · Form 8-K | -1.09% | -2.83% | |
| Form S-4/A ARCA biopharma, Inc. | SEC filing · Form S-4 | -1.09% | -2.83% | |
| Form S-4/A ARCA biopharma, Inc. | SEC filing · Form S-4 | +0.00% | -0.61% | |
| Form S-4 ARCA biopharma, Inc. | SEC filing · Form S-4 | -0.87% | -3.77% | |
| Form 10-Q ARCA biopharma, Inc. For: Mar 31 | SEC filing · Form 10-Q | -2.99% | -2.72% | |
| Form 8-K ARCA biopharma, Inc. For: Apr 25 | SEC filing · Form 8-K | -2.99% | -2.72% | |
| Form 8-K ARCA biopharma, Inc. For: Apr 20 | SEC filing · Form 8-K | +1.10% | -0.28% | |
| Form 8-K ARCA biopharma, Inc. For: Apr 02 | SEC filing · Form 8-K | +2.70% | +4.39% | |
| Form 8-K ARCA biopharma, Inc. For: Apr 03 | SEC filing · Form 8-K | +9.97% | +11.68% | |
| Form 8-K ARCA biopharma, Inc. For: Mar 19 | SEC filing · Form 8-K | +0.00% | -2.81% | |
| Form 8-K ARCA biopharma, Inc. For: Feb 02 | SEC filing · Form 8-K | +1.26% | +0.63% | |
| Form 10-K ARCA biopharma, Inc. For: Dec 31 | SEC filing · Form 10-K | +0.00% | +3.19% | |
| Form 8-K ARCA biopharma, Inc. For: Feb 01 | SEC filing · Form 8-K | +0.00% | +3.19% | |
| Form 8-K ARCA biopharma, Inc. For: Jan 30 | SEC filing · Form 8-K | +0.63% | -1.26% | |
| Form ARS ARCA biopharma, Inc. For: Dec 31 | SEC filing · Form ARS | +0.00% | -1.15% | |
| Form DEF 14A ARCA biopharma, Inc. For: Jan 30 | SEC filing · Form DEF | +0.00% | -1.15% | |
| Form DEFA14A ARCA biopharma, Inc. | SEC filing · Form DEFA14A | +0.00% | -1.15% | |
| Form 8-K ARCA biopharma, Inc. For: Dec 04 | SEC filing · Form 8-K | — | +1.10% | |
| Form 8-K ARCA biopharma, Inc. For: Nov 29 | SEC filing · Form 8-K | +0.00% | +1.94% |
Keep exploring
More ABIO: earnings → · analyst actions → · ABIO overview →
Other Healthcare names and their SEC filings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Sienna Senior Living Inc (SIA_TSE) | 101 | +0.25% | 65% |
| Mynd.ai, Inc. American Depositary Shares (MYND) | 100 | +0.52% | 58% |
| Axonics, Inc. (AXNX) | 99 | +0.01% | 51% |
| Novo Integrated Sciences, Inc. (NVOS) | 99 | 0.00% | 42% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its SEC filings — that is what the link opens.